A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Clinical trial NCT06260748 · WITHDRAWN
Trial details
- NCT number
- NCT06260748
- Sponsor
- Leadiant Biosciences, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2025-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.